Kazuko Kaneda‐Nakashima
- Oncology top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Molecular Biology
- Immunology top 10%
- Surgery
- Co-authors
- Atsushi ToyoshimaKazuhiro OoeYoshifumi ShirakamiTadashi WatabeAtsushi ShinoharaJun HatazawaYuwei LiuTaro Shirakawa
- Topics
- Radiopharmaceutical Chemistry and Applications (20 papers)Peptidase Inhibition and Analysis (10 papers)Amino Acid Enzymes and Metabolism (9 papers)
- Partner nations
- JapanGermanyUnited States
In The Last Decade
Kazuko Kaneda‐Nakashima
66 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 118
- Oncology 552
- Radiology, Nuclear Medicine and Imaging 451
- Molecular Biology 378
- Immunology 369
- Surgery 246
Countries citing papers authored by Kazuko Kaneda‐Nakashima
This map shows the geographic impact of Kazuko Kaneda‐Nakashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuko Kaneda‐Nakashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuko Kaneda‐Nakashima more than expected).
Fields of papers citing papers by Kazuko Kaneda‐Nakashima
This network shows the impact of papers produced by Kazuko Kaneda‐Nakashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuko Kaneda‐Nakashima. The network helps show where Kazuko Kaneda‐Nakashima may publish in the future.
Co-authorship network of co-authors of Kazuko Kaneda‐Nakashima
This figure shows the co-authorship network connecting the top 25 collaborators of Kazuko Kaneda‐Nakashima. A scholar is included among the top collaborators of Kazuko Kaneda‐Nakashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuko Kaneda‐Nakashima. Kazuko Kaneda‐Nakashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 9 | |
| 5 | 0 | |
| 6 | 2 | |
| 7 | 2 | |
| 8 | 4 | |
| 9 | 12 | |
| 10 | 19 | |
| 11 | 13 | |
| 12 | 9 | |
| 13 | 35 | |
| 14 | 228 | |
| 15 | 12 | |
| 16 | 56 | |
| 17 | 14 | |
| 18 | 11 | |
| 19 | 41 | |
| 20 | 23 |
About Kazuko Kaneda‐Nakashima
Kazuko Kaneda‐Nakashima is a scholar working on Biochemistry, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy, having authored 69 papers that have together received 1.7k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (20 papers), Peptidase Inhibition and Analysis (10 papers) and Amino Acid Enzymes and Metabolism (9 papers). The work is most often cited by research in Oncology (552 citations), Radiology, Nuclear Medicine and Imaging (451 citations) and Biochemistry (128 citations). Kazuko Kaneda‐Nakashima has collaborated with scholars based in Japan, Germany and United States. Frequent co-authors include Atsushi Toyoshima, Kazuhiro Ooe, Yoshifumi Shirakami, Tadashi Watabe, Atsushi Shinohara, Jun Hatazawa, Yuwei Liu, Taro Shirakawa, Eku Shimosegawa and Frederik L. Giesel. Their work appears in journals such as PLoS ONE, Molecular and Cellular Biology and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.